Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin and baclofen in cardiovascular disease (France, CHU Toulouse)
2010-022881-28Phase 4Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jun 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A and baclofen in cardiac morbidity, sponsored by Centre hospitalier universitaire de Toulouse. Started Jun 2015; status: completed.
02
Drugs
botulinum toxin type Abaclofen
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on 2010-022881-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022881-28.